Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04335331 · ClinicalTrials.gov registry record
PreDM Clinical Decision Support Intervention
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 7,424
- Enrollment target
NCT04335331 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 7,424 participants.
The verdict
NCT04335331 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 7,424 participants
- Enrollment target
Study Summary
Clinical practice guidelines recommend intensive lifestyle interventions and metformin to prevent or delay type 2 diabetes; yet these treatments are not routinely used among the 86 million U.S. adults with prediabetes who may benefit from them. While clinical decision support (CDS) represents an effective approach for delivering guideline-based care, the potential of this strategy to improve diabetes prevention efforts has not been definitively tested. This study developed the novel Prevent Diabetes Mellitus Clinical Decision Support (PreDM CDS) intervention and evaluated its impact on clinical outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,424 participants |
| Start Date | 2020-02-27 |
| Est. Completion | 2022-09-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04335331
The ClinicalTrials.gov registry entry for NCT04335331 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,424 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04335331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04335331 about?
NCT04335331 is a clinical study titled "PreDM Clinical Decision Support Intervention". Clinical practice guidelines recommend intensive lifestyle interventions and metformin to prevent or delay type 2 diabetes; yet these treatments are not routinely used among the 86 million U.S. adults with prediabetes who may benefit from them. While clinical decision support (CDS) represents an eff...
What is the current status of trial NCT04335331?
This trial is currently completed. The enrollment target is 7,424 participants. The study started on 2020-02-27. Estimated completion is 2022-09-02.
Who is sponsoring clinical trial NCT04335331?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.